Solid Innovation for Green Tomorrow! XCMG Excavator Hosts 7th International Customer Festival in Xuzhou
XUZHOU, China, May 27, 2025 /PRNewswire/ -- The 7th XCMG International Customer…
XCMG Champions “Solid Innovation for a Green Tomorrow” at 7th International Customer Festival
XUZHOU, China, May 28, 2025 /PRNewswire/ -- Xuzhou Construction Machinery Group Co., Ltd.…
Cango Inc. Reports Q1 2025 Bitcoin Mining Revenue Meets Apollo Insights’ Expectations, Firm Highlights Solid Operational Metrics and Growth Potential
SHANGHAI, May 19, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the…
Virbac: In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope
In the first quarter of 2025, revenue recorded solid growth of +4.9%…
Olympic Agenda lays solid longterm financial base for IOC with revenues up by 60 per cent during the period of implementation
19 March 2025 – The reforms of Olympic Agenda have created a solid long-term…
Solid Innovation For Green Tomorrow: XCMG to Launch New Energy Series and Lineup Over 40 Flagship Products at bauma 2025
MUNICH, March 17, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE:000425) is set to…
Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports
MILPITAS, Calif., Feb. 18, 2025 /PRNewswire/ -- The global semiconductor manufacturing industry closed…
Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines
January 15, 2025 16:05 ET | Source: Solid Biosciences Inc. - Duchenne:…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…
Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext…